Miist Therapeutics
PrivateLast Round
Seed
Feb 5, 2025
Total Funding Raised
$7M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Miist Therapeutics is a biotechnology company that develops inhaled therapies designed for rapid symptom relief using proprietary aerosol physics technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miist Therapeutics Comparables
Compare Miist Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qnovia | 81% | |
| Transpire Bio Inc. | 73% | |
| Pulmatrix, Inc. | 65% | |
Miist Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 5, 2025 |
Miist Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Seed |
| 1517 Fund | Seed |
| California Innovation Fund | Seed |
| Freeflow Ventures | Seed |
| Freeflow Ventures | Seed |
| Entrepreneurs First | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors grew 430% MoM.
- Feb 5, 2025
$7M round completed.
Miist Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Miist Therapeutics's valuation, stock price, and market status.